Synthesis and Biological Evaluation of 7-(2-Chlorophenylamino)-5-((2- [18F]fluoro-ethyoxy)methyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile as PET Tumor Imaging Agent

Jingli Xu,Hang Liu,Guixia Li,Yong He,Rui Ding,Xiao Wang,Man Feng,Shuting Zhang,Yurong Chen,Shilei Li,Mingxia Zhao,Yingruo Li,Chuanmin Qi
DOI: https://doi.org/10.5560/znb.2012-0047
2012-08-01
Abstract:An 18F-labeled pyrazolo[1,5-a]pyrimidine derivative, 7-(2-chlorophenylamino)-5-((2-[18F] fluoroethyoxy)methyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile ([18F]5), has been designed and prepared as a radio tracer candidate for tumor detection with positron emission tomography (PET). The desired product [18F]5was synthesized by nucleophilic substitution of the corresponding tosylated precursor with [18F]KF=Kryptofix 2.2.2 and potassium carbonate in anhydrous DMF at 100 °C for 20 min followed by purification with HPLC. The radiochemical purity was >98%, and the radio-chemical yield was 25% (decay-uncorrected). Compound [18F]5was very stable in vitro. The biodistribution study in mice bearing S180 tumors demonstrated that [18F]5had a rapid and prolonged accumulation in tumors with moderate washout from other tissues Graphical Abstract Synthesis and Biological Evaluation of 7-(2-Chlorophenylamino)-5-((2- [18F]fluoro-ethyoxy)methyl)pyrazolo[1,5-a]pyrimidine-3-carbonitrile as PET Tumor Imaging Agent
What problem does this paper attempt to address?